Assessing Social Determinants of Health to Increase Cancer Screening
Part of paid clinical trials in Nutley, New Jersey.
- Sponsor
- Hackensack Meridian Health
- Study ID
- NCT06052449
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 80 Years
- Healthy Volunteers
- Accepted
Interventions
- Social determinants of health screening assessment and referral process — BEHAVIORALUnite Us is an electronic SDoH screening and referral tool assessing: (1) financial resource strain; (2) housing stability; (3) transportation needs; and (4) food insecurity. Upon completion, the Unite Us platform identifies a list of geographically-tailored resources to connect the individual in need. A staff member will administer the SDoH screening and referral tool, review the results with the participant, and use the geographically-tailored resources to make SDoH-related referrals.
- Current practice - Community-based lunch cancer screening (LungTalk) — BEHAVIORALThe current practice during community events is to offer LungTalk. LungTalk is a novel theoretically grounded health educational tool that will be delivered via iPad and is an interactive computer-based program that includes audio, video and animation segments with scripts presented from a master content library in consideration of different ways people like to learn. Informed by our prior research, LungTalk tailors its content based on smoking status and perceived barriers.
Study Details
A multilevel lung screening intervention that pairs Social Determinants of Health (SDoH) screening and referral with a tailored health communication and decision support tool for lung screening has the potential to significantly impact lung screening uptake among at-risk individuals in the community, particularly among those who face barriers related to SDoH. In addition, findings will advance the understanding of effective strategies for improving lung screening and prevention efforts in non-traditional settings, with the ultimate goal of reducing the burden of lung cancer. As ways to support the realization of the public health benefit of lung cancer screening are considered, multiple strategies and venues to reach, and intervene, with screening-eligible is key. The goal of this study is to compare the effectiveness of a community-based lung screening educational tool paired with a social determinants of health (SDoH) screening assessment and referral process compared to a community-based lung cancer screening (LCS) educational tool alone as part of community outreach activities to improve (a) LCS rates (primary outcome); (b) intention to screen; and (c) individual-level potential drivers of LCS (health literacy, mistrust, stigma, fatalism, knowledge, health beliefs). It is hypothesized that providing SDoH screening and referral will result in higher levels of LCS, forward movement of intention to screen, and improved individual-level drivers of LCS.
Key Dates
- Start date
- Sep 30, 2023
- Status verified
- Feb 2026
- Primary completion
- Aug 19, 2025
- Completion
- Aug 19, 2025
Study Design
- Enrollment
- 101 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SCREENING
Arms
- Experimental: Social determinants of health screeningParticipants will receive a social determinants of health screening assessment and referral process in addition to the community-based lung cancer screening educational tool.
- Active Comparator: Community-based lung cancer screeningParticipants will receive a community-based lung cancer screening educational tool.
Primary Outcome Measure
Lung Cancer Screening Uptake [ Time Frame: 1 months post intervention ]
Locations (1)
| Facility | City | State | ZIP |
|---|---|---|---|
| Hackensack Meridian Health - Center for Discovery and Innovation | Nutley | New Jersey | 07110 |
Find similar trials in Nutley, NJ
Related Studies
- Collection of Sputum and Labeling for Lung CancerRecruiting · bioAffinity Technologies Inc. · Summit, New Jersey
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPHASE1/PHASE2 · Recruiting · VM Oncology, LLC · Santa Rosa, California
- Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With SurgeryPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS BronchoscopyRecruiting · The Cooper Health System · Camden, New Jersey